Cigarette Smoking Has no Impact on the Effect of Radioiodine Therapy in Patients with Graves Disease
Journal Title: Acta Facultatis Medicae Naissensis - Year 2015, Vol 32, Issue 1
Abstract
Presently, there is very little data on the impact of nicotine and other components of tobacco smoking on the outcome of radioiodine therapy (RIT) in Graves’ disease (GD). Thus, this study was aimed to analyze a possible impact of cigarette smoking on the effect of radioiodine therapy in the patients with Graves’ disease. The study included 31 patients (16 smokers and 15 non-smokers) with GD, aged from 22 to 73 years, who were treated with a single dose of iodine-131 sodium iodide (131I-NaI) and subjected to a 12-month follow-up, thereafter. Patients were treated with antithyroid drugs (ATDs) before RIT and described very intense stressful events occurring prior to diagnosing Graves’ hyperthyroidism. A successful response to RIT was defined as euthyroidism and subclinical or clinical hypothyroidism, while an unsuccessful response was defined as persistent hyperthyroidism. Comparison of age (47.4±9.41 vs. 49.5±13.8 years, p=0.628) at the time of RIT, applied activity of 131I-NaI (372±78.4 vs. 363±43.7 MBq, p=0.675), and duration of ATDs therapy (3.47±3.33 vs. 4.94±5.62 years, p=0.387) between smokers and non-smokers showed no significant difference. The cumulative incidence of successful response to therapy in smokers and non-smokers was 31.2 vs. 46.7% (p<0.05), 50.0 vs. 60.0% (p>0.05), 56.2 vs. 60.0% (p>0.05), and 56.2 vs. 66.7% (p>0.05) after 3, 6, 9 and 12 months, respectively. The results showed that cigarette smoking has no impact on the effect of radioiodine therapy after twelve-month period in patients who had experienced stressful events before the occurrence of Graves’ disease. However, patients with smoking habits achieved successful response later than non-smokers.
Authors and Affiliations
Vladan Sekulić, Milena Rajić, Marina Vlajković, Slobodan Ilić, Miloš Stević, Ivana Mišić, Milan Božinović
Association of the A Allele of the TNF-Alpha-308 G/A Gene Polymorphism with Radiographic Progression in Rheumatoid Arthritis - - - Udruženost A alela polimorfizma -308 G/A gena za TNF alfa sa radiografskom progresijom reumatoidnog artritisa
To examine whether the presence of the rare A allele of the TNF-Alpha-308 G/A gene polymorphism is associated with erosive arthritis and rapid radiological progression of the disease. The examined group included 131 pati...
CLINICAL AND NEUROPHYSIOLOGICAL FEATURES IN PATIENTS PRESENTING CLINICALLY ISOLATED SYNDROME SUGGESTIVE ON MULTIPLE SCLEROSIS
Clinically isolated syndrome suggestive on multiple sclerosis is monophasic clinical presentation with suspected underlying inflammatory demyelinating disease. Clinically isolated syndrome supported with magnetic resonan...
NOVI LEKOVI U TERAPIJI OSTEOPOROZE: pregled 2. i 3. faze kliničkih istraživanja
Osteoporoza je hronična bolest koja je sve više zastupljena i to pretežno kod osoba ženskog pola. Postoje dokazi da bisfosfonati, selektivni modulatori estrogenskih receptora, denosumab, teriparatid i stroncijum ranelat...
EFIKASNOST INTRAVENOZNOG DAVANJA SUKROZE GVOŽĐA U LEČENJU ANEMIJE USLED NEDOSTATKA GVOŽĐA KOD BOLESNICA SA ABNORMALNIM KRVARENJEM IZ MATERICE
Anemija usled nedostatka gvožđa (IDA-eng.) je najčešći nutritivni poremećaj u svetu i javlja se češće kod žena u zemljama u razvoju nego u razvijenim zemljama. Anemija usled nedostatka gvožđa je kod odrasle ženske popula...
DIAGNOSIS AND CLINICAL IMPORTANCE OF HUMAN DIROFILARIOSIS
The dog parasites Dirofilaria immitis (D. immitis) and Dirofilaria repens (D. repens), well known as zoonotic agents, can infect humans with immature forms. Human dirofilarioses in many asymptomatic patients are undiagno...